Results 41 to 50 of about 179,002 (365)

Chronic graft-versus-host disease and its management in children [PDF]

, 2002
Chronic graft-versus-host disease is sometimes a severe, disabling and long-lasting complication of allogeneic hematopoietic stem cell transplantation.
Bakker, J.D.J., Breedeveld, L., Mertens, B., van Weel-Sipman, M.H., Vossen, J.M.   +4 more
core   +1 more source

Imbalance of effector and regulatory CD4 T cells is associated with graft-versus-host disease after hematopoietic stem cell transplantation using a reduced intensity conditioning regimen and alemtuzumab

Haematologica, 2009
Background A variety of immune pathways can lead to graft-versus-host disease. A better understanding of the type of immune response causing graft-versus-host disease in defined clinical hematopoietic stem cell transplant settings is required to inform ...
Katie Matthews, ZiYi Lim, Behdad Afzali, Laurence Pearce, Atiyeh Abdallah, Shahram Kordasti, Antonio Pagliuca, Giovanna Lombardi, J. Alejandro Madrigal, Ghulam J. Mufti, Linda D. Barber   +10 more
doaj   +1 more source

Cytokines in Graft-versus-Host Disease [PDF]

The Journal of Immunology, 2015
Abstract Graft-versus-host disease (GVHD) is a complication of allogeneic bone marrow transplantation whereby transplanted naive and marrow-derived T cells damage recipient tissue through similar mechanisms to those that allow destruction of malignant cells, the therapeutic intent of bone marrow transplantation.
Henden, Andrea S., Hill, Geoffrey R.
openaire   +4 more sources

Comparable composite endpoints after HLA-matched and HLA-haploidentical transplantation with post-transplantation cyclophosphamide

Haematologica, 2017
Composite endpoints that not only encompass mortality and relapse, but other critical post-transplant events such as graft-versus-host disease, are being increasingly utilized to quantify survival without significant morbidity after allogeneic blood or ...
Shannon R. McCurdy, Yvette L. Kasamon, Christopher G. Kanakry, Javier Bolaños-Meade, Hua-Ling Tsai, Margaret M. Showel, Jennifer A. Kanakry, Heather J. Symons, Ivana Gojo, B. Douglas Smith, Maria P. Bettinotti, William H. Matsui, Amy E. Dezern, Carol Ann Huff, Ivan Borrello, Keith W. Pratz, Douglas E. Gladstone, Lode J. Swinnen, Robert A. Brodsky, Mark J. Levis, Richard F. Ambinder, Ephraim J. Fuchs, Gary L. Rosner, Richard J. Jones, Leo Luznik   +24 more
doaj   +1 more source

Busulfan and melphalan as conditioning regimen for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia in first complete remission [PDF]

, 2011
BACKGROUND: Allogeneic hematopoietic stem cell transplantation with HLA-identical donors has been established for the treatment of acute myeloid leukemia patients for over 30 years with a cure rate of 50% to 60%.
AMIGO FILHO, José Ulysses, BUENO, Nadjanara Dorna, CHAMONE, Dalton de Alencar Fischer, CORACIN, Fabio Luiz, DULLEY, Frederico Luiz, SABOYA, Rosaura   +5 more
core   +2 more sources

Lichenoid variant of chronic cutaneous graft versus host reaction post blood transfusion: A rare event post blood transfusion

Indian Journal of Dermatology, 2015
Chronic graft versus host disease (GVHD) is a less frequently seen disease that occurs post solid organ or bone marrow transplantation. Chronic GVHD occurring post blood transfusion is an even more uncommon disease.
Pushpa Kodipalya Ramakrishnaiah, Archana Lakshman, Sacchidanand Sarvajnamurthy Aradhya, Nataraja Holavanahally Veerabhadrappa   +3 more
doaj   +1 more source

CheXseen: Unseen Disease Detection for Deep Learning Interpretation of Chest X-rays [PDF]

arXiv, 2021
We systematically evaluate the performance of deep learning models in the presence of diseases not labeled for or present during training. First, we evaluate whether deep learning models trained on a subset of diseases (seen diseases) can detect the presence of any one of a larger set of diseases.
arxiv  

Minors come of age: minor histocompatibility antigens and graft-versus-host disease [PDF]

, 2004
Minor histocompatibility antigens (miHA) are responsible for the occurrence of graft-versus-host disease in the setting of a major histocompatibility complex matched sibling allogeneic stem cell transplantation.
Chao, Nelson J
core   +1 more source

Ontology Based Information Extraction for Disease Intelligence [PDF]

International Journal of Research in Computer Science, 2 (6): pp. 7-19, November 2012. doi:10.7815/ijorcs.26.2012.051, 2012
Disease Intelligence (DI) is based on the acquisition and aggregation of fragmented knowledge of diseases at multiple sources all over the world to provide valuable information to doctors, researchers and information seeking community. Some diseases have their own characteristics changed rapidly at different places of the world and are reported on ...
arxiv   +1 more source

Post-transplant cyclophosphamide versus anti-thymocyte globulin as graft- versus-host disease prophylaxis in haploidentical transplant

Haematologica, 2017
Severe graft-versus-host disease is a major barrier for non-T-cell-depleted haploidentical stem cell transplantation. There is no consensus on the optimal graft-versus-host disease prophylaxis.
Annalisa Ruggeri, Yuqian Sun, Myriam Labopin, Andrea Bacigalupo, Francesca Lorentino, William Arcese, Stella Santarone, Zafer Gülbas, Didier Blaise, Giuseppe Messina, Ardeshi Ghavamzadeh, Florent Malard, Benedetto Bruno, Jose Luis Diez-Martin, Yener Koc, Fabio Ciceri, Mohamad Mohty, Arnon Nagler   +17 more
doaj   +1 more source